MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.390
+0.100 (7.75%)
May 29, 2026, 4:00 PM EDT - Market closed
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $84.51 million as of May 29, 2026. Its market cap has increased by 58.44% in one year.
Market Cap
84.51M
Enterprise Value
50.10M
1-Year Change
58.44%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $84.51M, an increase of 65.39%. That is a compound annual growth rate of 14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 84.51M | 44.35% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 90.00M |
| Aardvark Therapeutics | 89.67M |
| LeonaBio | 89.61M |
| Atara Biotherapeutics | 89.46M |
| Outlook Therapeutics | 88.23M |
| MindWalk Holdings | 87.41M |
| NeurAxis | 85.26M |
| eXoZymes | 83.48M |